Your browser doesn't support javascript.
loading
Viewpoint: Do not resurrect the two-stage procedure.
Senn, Stephen.
Afiliación
  • Senn S; School of Health and Related Research, Medical Statistics Group, University of Sheffield, Edinburgh, UK.
Pharm Stat ; 21(4): 808-814, 2022 07.
Article en En | MEDLINE | ID: mdl-35819114
In 1989, Peter Freeman published a paper that challenged a commonly accepted approach for analyzing cross-over trials, the so-called two-stage procedure. Freeman himself recommended using the Bayesian approach of Andy Grieve. The flaws Freeman exposed were serious and led many statisticians to conclude that the procedure was unacceptable. Unfortunately, more than 30 years later, one still encounters its use. This note explains, using a simple simulation, why the two-stage procedure is, indeed, as Freeman showed unacceptable and should not be used.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Teorema de Bayes Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans Idioma: En Revista: Pharm Stat Asunto de la revista: FARMACOLOGIA Año: 2022 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Teorema de Bayes Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans Idioma: En Revista: Pharm Stat Asunto de la revista: FARMACOLOGIA Año: 2022 Tipo del documento: Article